AAV-Ex-4 (NIDCR)

N/A

Report date: 2025/03/14 16:46:55

Base Information

Drug NameAAV-Ex-4 (NIDCR)
Drug Alias Nameadeno-associated virus vector-delivered exendin-4 (NIDCR)AAV-Ex-4
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Dental And Craniofacial Research
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthNational Institute Of Dental And Craniofacial Research
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A